Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx™ for Treatment of Acute Myocarditis


August 3, 2022

Cardiol Therapeutics Reports Results of 2022 Annual General Meeting


June 29, 2022

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT


June 27, 2022

Cardiol Therapeutics Announces At-The-Market Equity Offering Program


June 9, 2022

Cardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of Directors


May 19, 2022

Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-label Pilot Study of CardiolRx™ for Recurrent Pericarditis


May 17, 2022

Cardiol Therapeutics Announces Year-End 2021 Update on Operations


March 24, 2022

Cardiol Therapeutics to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit


March 22, 2022

Cardiol Therapeutics Appoints Jennifer M. Chao to its Board of Directors


March 15, 2022

2025 Cardiol Therapeutics. All right reserved.